vendredi 21 avril 2017

FDA approves near-copy of Remicade for immune disorders

Federal regulators have approved an alternative version of Remicade, an expensive drug widely used for rheumatoid arthritis and other immune system disorders

from ABC News: Health http://ift.tt/2pMJlSA
via HEALTH

Aucun commentaire:

Enregistrer un commentaire